310 related articles for article (PubMed ID: 34572523)
1. Shifting Gears in Precision Oncology-Challenges and Opportunities of Integrative Data Analysis.
Noh KW; Buettner R; Klein S
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572523
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology.
Huss R; Raffler J; Märkl B
Cancer Rep (Hoboken); 2023 Jul; 6(7):e1796. PubMed ID: 36813293
[TBL] [Abstract][Full Text] [Related]
3. Harnessing multimodal data integration to advance precision oncology.
Boehm KM; Khosravi P; Vanguri R; Gao J; Shah SP
Nat Rev Cancer; 2022 Feb; 22(2):114-126. PubMed ID: 34663944
[TBL] [Abstract][Full Text] [Related]
4. Novel omics technology driving translational research in precision oncology.
Basu A; Budhraja A; Juwayria ; Abhilash D; Gupta I
Adv Genet; 2021; 108():81-145. PubMed ID: 34844717
[TBL] [Abstract][Full Text] [Related]
5. Translational precision medicine: an industry perspective.
Hartl D; de Luca V; Kostikova A; Laramie J; Kennedy S; Ferrero E; Siegel R; Fink M; Ahmed S; Millholland J; Schuhmacher A; Hinder M; Piali L; Roth A
J Transl Med; 2021 Jun; 19(1):245. PubMed ID: 34090480
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
8. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
Mandal R; Chan TA
Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
[TBL] [Abstract][Full Text] [Related]
9. Status of Immune Oncology: Challenges and Opportunities.
Cesano A; Marincola FM; Thurin M
Methods Mol Biol; 2020; 2055():3-21. PubMed ID: 31502145
[TBL] [Abstract][Full Text] [Related]
10. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
[TBL] [Abstract][Full Text] [Related]
11. The Pros and Cons of Incorporating Transcriptomics in the Age of Precision Oncology.
Lin VTG; Yang ES
J Natl Cancer Inst; 2019 Oct; 111(10):1016-1022. PubMed ID: 31165154
[TBL] [Abstract][Full Text] [Related]
12. Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancer.
Fitzgerald J; Higgins D; Mazo Vargas C; Watson W; Mooney C; Rahman A; Aspell N; Connolly A; Aura Gonzalez C; Gallagher W
J Clin Pathol; 2021 Jul; 74(7):429-434. PubMed ID: 34117103
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers in Precision Cancer Immunotherapy: Promise and Challenges.
McKean WB; Moser JC; Rimm D; Hu-Lieskovan S
Am Soc Clin Oncol Educ Book; 2020 May; 40():e275-e291. PubMed ID: 32453632
[TBL] [Abstract][Full Text] [Related]
14. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
Ahmed Z
Hum Genomics; 2020 Oct; 14(1):35. PubMed ID: 33008459
[TBL] [Abstract][Full Text] [Related]
15. Discovery through clinical sequencing in oncology.
Donoghue MTA; Schram AM; Hyman DM; Taylor BS
Nat Cancer; 2020 Aug; 1(8):774-783. PubMed ID: 35122052
[TBL] [Abstract][Full Text] [Related]
16. Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support.
Chae YK; Pan AP; Davis AA; Patel SP; Carneiro BA; Kurzrock R; Giles FJ
Mol Cancer Ther; 2017 Dec; 16(12):2645-2655. PubMed ID: 29203694
[TBL] [Abstract][Full Text] [Related]
17. Dissection of gastric cancer heterogeneity for precision oncology.
Ho SWT; Tan P
Cancer Sci; 2019 Nov; 110(11):3405-3414. PubMed ID: 31495054
[TBL] [Abstract][Full Text] [Related]
18. The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.
Barbieri CE; Chinnaiyan AM; Lerner SP; Swanton C; Rubin MA
Eur Urol; 2017 Feb; 71(2):237-246. PubMed ID: 27567210
[TBL] [Abstract][Full Text] [Related]
19. Cancer management in terms of precision oncology.
Mali SB; Dahivelkar S
Oral Oncol; 2024 Jan; 148():106658. PubMed ID: 38056061
[TBL] [Abstract][Full Text] [Related]
20. Integrating proteomics into precision oncology.
Wahjudi LW; Bernhardt S; Abnaof K; Horak P; Kreutzfeldt S; Heining C; Borgoni S; Becki C; Berg D; Richter D; Hutter B; Uhrig S; Pfütze K; Leichsenring J; Glimm H; Brors B; von Kalle C; Stenzinger A; Korf U; Fröhling S; Wiemann S
Int J Cancer; 2021 Mar; 148(6):1438-1451. PubMed ID: 32949162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
